Avelo

    Avelo2022-09-20T14:04:48+01:00

    COMPANY INFO

    MEDTECH – Switzerland

    Current stage: Seed

    AVELO

    COMPANY PROFILE

    Avelo is a Swiss breath diagnostics company with a mission to save lives by bringing fast and actionable infectious disease diagnoses to primary care.

    NEWS

    • Avelo

    Avelo is part of the new EUR 3 million “BreathForDx” project, funded by the Horizon Europe program and co-funded by SERI.

    May 14th, 2024|

    Read More
    • AVELO

    Avelo receives CHF 1.5M Innosuisse Grant to Deliver an Innovative Breath Sampling Tool for LRTIs

    December 14th, 2023|

    Read More

    Avelo closes CHF 2.2 million oversubscribed seed round

    September 20th, 2022|

    Read More
    © Copyright -  | Privilège Ventures SA  | All Rights Reserved | 
    LinkedIn